RNASeq Summit
Date: | 24-Apr-18 to 26-Apr-18 |
Location: | Le Méridien, / United States |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
The 6th RNA Seq Summit provides a vital forum for practitioners to come up to speed with the latest advances in RNA-Seq technologies and analytical tools, as well as help devise solutions to key challenges surrounding
drug development and clinical applications of RNA-Seq.
Harness the next generation of RNA-Seq methods to find the signal amongst the noise when overcoming the analytical and processing challenges of RNA-Seq data. Deepen your understanding of disease biology through optimized application of RNA-Seq methods, and improve your drug discovery, biomarker and clinical applications as RNA-Seq storms into the clinic. This year’s agenda has been designed specifically for the RNA-Seq community by fore-thinkers in the industry with a greater focus on single-cell RNA-Seq, bioinformatics approaches and the clinical applications of RNA-Seq.
What’s new to RNA-Seq 2018?
1. Discover how BMS are carrying out integrated analysis by co-extraction of RNA, DNA and protein from FFPE Tumour samples
2. Gain new insights into RNA-Seq for the study of viral transcripts, data visualization, gene fusion identification and more from companies such as Genetech, GSK, BMS, Merck, The Mayo Clinic and UCSC Genome Browser
3. Explore new solutions to:
- Roadblocks in applying single cell and other emerging RNA sequencing technologies in the clinic
- Accurately interpreting the vast amounts of data in unpicking the complexity of the transcriptome
- Integrating and mining of RNA-Seq data for drug discovery research
- Novel and innovative RNA-Seq methods to understand the impact of tissue composition and cellular interactions
drug development and clinical applications of RNA-Seq.
Harness the next generation of RNA-Seq methods to find the signal amongst the noise when overcoming the analytical and processing challenges of RNA-Seq data. Deepen your understanding of disease biology through optimized application of RNA-Seq methods, and improve your drug discovery, biomarker and clinical applications as RNA-Seq storms into the clinic. This year’s agenda has been designed specifically for the RNA-Seq community by fore-thinkers in the industry with a greater focus on single-cell RNA-Seq, bioinformatics approaches and the clinical applications of RNA-Seq.
What’s new to RNA-Seq 2018?
1. Discover how BMS are carrying out integrated analysis by co-extraction of RNA, DNA and protein from FFPE Tumour samples
2. Gain new insights into RNA-Seq for the study of viral transcripts, data visualization, gene fusion identification and more from companies such as Genetech, GSK, BMS, Merck, The Mayo Clinic and UCSC Genome Browser
3. Explore new solutions to:
- Roadblocks in applying single cell and other emerging RNA sequencing technologies in the clinic
- Accurately interpreting the vast amounts of data in unpicking the complexity of the transcriptome
- Integrating and mining of RNA-Seq data for drug discovery research
- Novel and innovative RNA-Seq methods to understand the impact of tissue composition and cellular interactions
Exhibitors
Principal Scientist - Bioinformatics & Computational Biology – Genentech, Professor & Director of Genome Informatics - Rutgers New Jersey Medical School, Scientist – GSK, Co-Director - Genome Analysis Core - Mayo Clinic, Director - Genomics - BMS, Scientist - Stanford University, Principal - Garvan Institute of Medical Research, Research Associate Professor - Director of High Throughput Sequencing Facility - UNC, CTO - UCSC Genomics Institute, Associate Professor - Mayo Clinic, Computational Biology Scientist - Biogen, Associate Director - Genome Browser UCSC, COO - Cellecta, Senior Principal Scientist - QIAGEN, Global Product Manager - Qiagen
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today